In hematological malignancies, donor T cells from donor lymphocyte infusions targeting the ubiquitously expressed MiHA peptides can induce complete remissions by GVL, albeit frequently accompanied by concurrent GVHD [47]. Here, XIAP is linked to graft versus host disease.